Lanxia Meng

1.6k total citations · 1 hit paper
52 papers, 1.1k citations indexed

About

Lanxia Meng is a scholar working on Neurology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Lanxia Meng has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Neurology, 20 papers in Physiology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Lanxia Meng's work include Parkinson's Disease Mechanisms and Treatments (25 papers), Alzheimer's disease research and treatments (20 papers) and Cellular transport and secretion (7 papers). Lanxia Meng is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (25 papers), Alzheimer's disease research and treatments (20 papers) and Cellular transport and secretion (7 papers). Lanxia Meng collaborates with scholars based in China, United States and Sweden. Lanxia Meng's co-authors include Zhentao Zhang, Mingyang He, Lina Pan, Zhihui Fu, Li Zou, Lijun Dai, Xingyu Zhang, Guiqin Chen, Xin Yuan and Ye Tian and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Lanxia Meng

51 papers receiving 1.1k citations

Hit Papers

Propagation of pathologic α-synuclein from kidney to brai... 2025 2026 2025 5 10 15

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lanxia Meng China 18 436 365 283 235 192 52 1.1k
Eun Hee Ahn South Korea 27 840 1.9× 501 1.4× 359 1.3× 237 1.0× 453 2.4× 54 1.8k
Alessia Filippone Italy 22 558 1.3× 227 0.6× 170 0.6× 187 0.8× 114 0.6× 78 1.4k
Andreia Barateiro Portugal 20 603 1.4× 424 1.2× 87 0.3× 277 1.2× 111 0.6× 34 1.6k
Lihui Zhang China 20 374 0.9× 217 0.6× 101 0.4× 272 1.2× 123 0.6× 70 1.1k
Dong Young Choi South Korea 17 536 1.2× 489 1.3× 160 0.6× 605 2.6× 216 1.1× 21 1.5k
Chun‐Sung Sung Taiwan 21 286 0.7× 388 1.1× 76 0.3× 117 0.5× 261 1.4× 59 1.3k
Arundhati Jana United States 23 931 2.1× 449 1.2× 217 0.8× 517 2.2× 256 1.3× 27 2.0k
Ning Song China 33 668 1.5× 365 1.0× 828 2.9× 546 2.3× 424 2.2× 83 2.2k

Countries citing papers authored by Lanxia Meng

Since Specialization
Citations

This map shows the geographic impact of Lanxia Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanxia Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanxia Meng more than expected).

Fields of papers citing papers by Lanxia Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanxia Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanxia Meng. The network helps show where Lanxia Meng may publish in the future.

Co-authorship network of co-authors of Lanxia Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Lanxia Meng. A scholar is included among the top collaborators of Lanxia Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanxia Meng. Lanxia Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Xin, Shuke Nie, Danhao Xia, et al.. (2025). Propagation of pathologic α-synuclein from kidney to brain may contribute to Parkinson’s disease. Nature Neuroscience. 28(3). 577–588. 19 indexed citations breakdown →
2.
Xia, Danhao, Lanxia Meng, Jiehui Chen, et al.. (2024). Microglia Process α‐Synuclein Fibrils and Enhance their Pathogenicity in a TREM2‐Dependent Manner. Advanced Science. 12(7). e2413451–e2413451. 2 indexed citations
3.
Zhang, Li, Guoxin Zhang, Yan Liu, et al.. (2024). The PM20D1-NADA pathway protects against Parkinson’s disease. Cell Death and Differentiation. 31(11). 1545–1560. 3 indexed citations
4.
Yuan, Lin, Na Cui, Cong Feng, et al.. (2023). α‐Synuclein induces deficiency in clathrin‐mediated endocytosis through inhibiting synaptojanin1 expression. Journal of Neurochemistry. 167(3). 461–484. 3 indexed citations
5.
Dai, Lijun, Jiannan Wang, Xingyu Zhang, et al.. (2023). 27‐Hydroxycholesterol Drives the Spread of α‐Synuclein Pathology in Parkinson's Disease. Movement Disorders. 38(11). 2005–2018. 13 indexed citations
6.
Meng, Lanxia, Congcong Liu, Miao Liu, et al.. (2023). The yeast protein Ure2p triggers Tau pathology in a mouse model of tauopathy. Cell Reports. 42(11). 113342–113342. 6 indexed citations
7.
Xiong, Min, et al.. (2023). The γ-Adducin 1–357 fragment promotes tau pathology. Frontiers in Aging Neuroscience. 15. 1241750–1241750. 3 indexed citations
8.
Xu, Xiaobo, et al.. (2022). Proteomic Analysis of Exudates from Chronic Ulcer of Diabetic Foot Treated with Scorpion Antimicrobial Peptide. Mediators of Inflammation. 2022. 1–16. 5 indexed citations
9.
Meng, Lanxia, Li Zou, Min Xiong, et al.. (2022). A synapsin Ⅰ cleavage fragment contributes to synaptic dysfunction in Alzheimer's disease. Aging Cell. 21(5). e13619–e13619. 18 indexed citations
10.
Liu, Chaoyang, Zehua Liu, Zhibing Zhang, et al.. (2022). Exposure to dithiocarbamate fungicide maneb in vitro and in vivo: Neuronal apoptosis and underlying mechanisms. Environment International. 171. 107696–107696. 12 indexed citations
11.
Tian, Ye, Lina Pan, Xin Yuan, et al.. (2022). 7,8-Dihydroxyflavone ameliorates mitochondrial impairment and motor dysfunction in the α-synuclein 1–103 transgenic mice. Neurobiology of Disease. 169. 105736–105736. 7 indexed citations
12.
Zhou, Lingyan, Tao Guo, Lanxia Meng, et al.. (2022). N‐homocysteinylation of α‐synuclein promotes its aggregation and neurotoxicity. Aging Cell. 22(3). e13745–e13745. 20 indexed citations
13.
Li, Sicheng, et al.. (2022). Role of defensins in diabetic wound healing. World Journal of Diabetes. 13(11). 962–971. 10 indexed citations
14.
Kang, Seong Su, Lanxia Meng, Xingyu Zhang, et al.. (2022). Tau modification by the norepinephrine metabolite DOPEGAL stimulates its pathology and propagation. Nature Structural & Molecular Biology. 29(4). 292–305. 34 indexed citations
15.
Yuan, Xin, Danhao Xia, Lanxia Meng, et al.. (2022). Silica Nanoparticles Promote α-Synuclein Aggregation and Parkinson’s Disease Pathology. Frontiers in Neuroscience. 15. 807988–807988. 17 indexed citations
16.
Zou, Li, Xingyu Zhang, Min Xiong, et al.. (2021). Asparagine endopeptidase cleaves synaptojanin 1 and triggers synaptic dysfunction in Parkinson's disease. Neurobiology of Disease. 154. 105326–105326. 14 indexed citations
17.
Yang, Jiaolong, et al.. (2020). TREM2 ectodomain and its soluble form in Alzheimer’s disease. Journal of Neuroinflammation. 17(1). 204–204. 73 indexed citations
18.
Li, Yiyi, Xuan Niu, Haitao Xu, et al.. (2020). VX-765 attenuates atherosclerosis in ApoE deficient mice by modulating VSMCs pyroptosis. Experimental Cell Research. 389(1). 111847–111847. 85 indexed citations
19.
Meng, Lanxia, Lijun Dai, Xingyu Zhang, et al.. (2020). Cofilin 1 promotes the aggregation and cell-to-cell transmission of α-synuclein in Parkinson’s disease. Biochemical and Biophysical Research Communications. 529(4). 1053–1060. 11 indexed citations
20.
Meng, Lanxia, Mingyang He, Min Xiong, et al.. (2018). 2′,3′-Dideoxycytidine, a DNA Polymerase-β Inhibitor, Reverses Memory Deficits in a Mouse Model of Alzheimer’s Disease. Journal of Alzheimer s Disease. 67(2). 515–525. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026